Treatment Advancements in Atopic Dermatitis With JAK Inhibitors: Updates for Pharmacists | PTCE Pharmacy Connect

The educational objectives are: • Review the pathophysiology of atopic dermatitis (AD) as well as the efficacy and safety data for topical JAK inhibitors that are approved and in development • Discuss the role of pharmacists as a part of the care team for patients with AD as well as the key counseling points and monitoring parameters Faculty: Dennis Williams Moderator: Jamie McConaha